Transcutaneous electrical nerve stimulation for advanced cancer pain inpatients in specialist palliative care-a blinded, randomized, sham-controlled pilot cross-over trial.
Waldemar SiemensChristopher BoehlkeMichael R BennettKlaus OffnerGerhild BeckerJan GaertnerPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
TENS was safe, but IMT was unlikely to offer more analgesic effects than PBT. Even though many patients desired a TENS prescription, 50% still reported at least "slight pain relief" from PBT. Differences for gender and incident pain aspects demand future trials.
Keyphrases
- palliative care
- advanced cancer
- chronic pain
- neuropathic pain
- pain management
- study protocol
- phase iii
- double blind
- end stage renal disease
- placebo controlled
- newly diagnosed
- open label
- ejection fraction
- clinical trial
- chronic kidney disease
- spinal cord
- spinal cord injury
- randomized controlled trial
- prognostic factors
- current status
- patient reported outcomes
- anti inflammatory
- postoperative pain